Anti-Tissue Transglutaminase Immunoglobulin A (tTG IgA)
tTg-IgA is a highly specific marker for diagnosing coeliac disease and monitoring its management.
About This Biomarker
Why We Test This
What Affects It
How to Improve
Understanding Your Results (FLU)
Low
Undetectable levels are expected in individuals without coeliac disease or those with coeliac disease on a strictly gluten-free diet. However, if coeliac symptoms persist, IgA deficiency should be investigated, as this can cause false-negative results.
Optimal
Normal tTg-IgA levels generally indicate no significant immune response to gluten, suggesting the absence of coeliac disease. For individuals with coeliac disease who are on a gluten-free diet, normal levels signify effective dietary management and healing of the intestinal lining.
Levels nearing the upper limit may suggest the early stages of coeliac disease or incomplete adherence to a gluten-free diet. This scenario often warrants further testing, such as a gluten challenge or biopsy, especially if symptoms are present. A careful review of dietary habits is essential to rule out unintentional gluten exposure.
Low but detectable levels are not clinically significant in most cases. For individuals with coeliac disease on a strict gluten-free diet, it reflects adherence and effective management of the condition.
High
Elevated tTg-IgA levels strongly suggest coeliac disease. High levels indicate an active immune response where the body is attacking its intestinal lining due to gluten ingestion. This is a significant sign of autoimmune activity, and further investigation, including a biopsy of the small intestine, is often needed for a definitive diagnosis. Continued high levels after a confirmed diagnosis might indicate accidental gluten exposure or non-compliance with a gluten-free diet.
Also known as: Anti-Tissue transglutaminase IgA (tTg-IgA), TTG IgA, TTG IgA (human recombinant), Anti-Tissue Transglutaminase Immunoglobulin A, TTG-IgA